ilmscore | Prediction Details
"regeneron Pharmaceuticals tier RN with no history of splitting its stock but a steady 272 return over the past 5 years that might convince the board that the shares have run too high on that price"
By Let's Talk Money! with Joseph Hogue, CFA | June 17, 2024 | Pending
From video
10 Stocks to Buy BEFORE They Split Next 00:11:00 - 00:11:11
Interpreted Prediction
Regeneron Pharmaceuticals (REGN) is identified as a potential candidate for a stock split.

Prediction Details

Ticker
REGN

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.